Ube has agreed to acquire all of the shares of the CDMO and API manufacturer

Patent expirations are creating opportunities in crop protection, while the speciality chemicals market as a

Following on from a decision last year to evaluate options to boost value, the board

Cell engineering company Ginkgo Bioworks has acquired the troubled synthetic biology specialist Zymergen for a

Solvay has announced plans to invest in an electronic-grade hydrogen peroxide (eH2O2

The American Chemistry Council (ACC) has filed a petition in DC Circuit Court challenging the

A registration statement has been filed with the US Securities & Exchange Commission (SEC) concerning

Researchers at the University of Glasgow have published a paper demonstrating a new and more

Oliver Cushing, CEO of RightsDD, looks at the possible impact of a new

Italian firm Olon has presented its new division, Olon Biotech, which will offer CDMO services